Company Update

Boston Bio Systems Limited has announced that it is exempt from submitting the Annual Secretarial Compliance Report for the financial year due to its paid-up equity share capital of ₹7.00 Cr and net worth of ₹6.45 Cr, both below the specified thresholds.

The company will comply with these requirements if it exceeds the limits in future.

This relief reduces compliance burden while maintaining readiness to adhere to governance standards when applicable, benefiting shareholders by focusing resources on operations.